Resolution No. 108-2-12
Title: Virtual Manufacturers and Wholesale Distributors
Whereas, a primary responsibility of the boards of pharmacy is to protect the integrity of our nation’s drug supply; and
Whereas, there has been a rapid increase in the number of entities that engage in the wholesale distribution of drug products without taking physical possession of the drug including, but not limited to, brokers, whose operations may be referred to as “virtual manufacturers” and “virtual wholesale distributors,” which may increase the risk of introducing counterfeit drugs into the United States drug supply chain; and
Whereas, the National Association of Boards of Pharmacy (NABP) Verified-Accredited Wholesale Distributors (VAWD) program has proven its value in confirming compliance with state and federal laws and regulations and established standards of practice of traditional manufacturers and wholesale distributors and, thus, deterring the introduction of counterfeit drugs into the US drug supply chain;
THEREFORE BE IT RESOLVED that NABP review and revise its standards for the VAWD program to define and address virtual manufacturers and wholesale distributors and amend the Model State Pharmacy Act and Model Rules of the National Association of Boards of Pharmacy if necessary.
(Resolution passed at the NABP 108th Annual Meeting, Philadelphia, PA)